STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 1st, 2010 • Steel Partners, Ltd. • In vitro & in vivo diagnostic substances • New York
STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of October 21, 2010, by and among Ore Pharmaceutical Holdings Inc., a Delaware corporation, with headquarters located at One Main Street, Suite 300, Cambridge, Massachusetts 02142 (the “Company”), and Steel Partners, Ltd., a Delaware corporation (“Buyer”).
JOINT FILING AGREEMENTJoint Filing Agreement • November 1st, 2010 • Steel Partners, Ltd. • In vitro & in vivo diagnostic substances
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $.01 par value, of Ore Pharmaceutical Holdings Inc.. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
